Original Article
Outcome in Childhood Guillain-Barré Syndrome
Veena Kalra, Naveen Sankhyan, Suvasini Sharma, Sheffali Gulati, Rama Choudhry1 and
Benu Dhawan1
Departments of Pediatrics and 1Microbiology, All India Institute of Medical Sciences, New Delhi, India
                                                          ABSTRACT
Objective. To assess the outcome of children diagnosed with Guillain-Barré syndrome (GBS), followed up for a median
duration of 25 months.
Methods. Tertiary center, prospective follow up of children with GBS enrolled from Dec 2003 through Sep 2006. Functional
recovery was determined at 12 months and later using Hughes scale (0-6). Clinical, electrophysiological variables were
compared between the good outcome (grade 0/1) and bad outcome groups (died or functional grade >1).
Results. Among 52 children with a median age of five yr there was male preponderance (75.4%). Mortality during acute
phase was 11.5% (6/52). Among the survivors long term data was obtainable in 40 of the 46 children. At one year follow up
87.5% children had fully recovered or had minimal symptoms, beyond one year this rose to 95%. Only 2 among 40 had
significant symptoms at last follow up (1 grade-2 and 1 grade-3). Factors significantly associated with poor outcome were:
need for artificial ventilation, inexitable nerves on nerve conduction testing and delayed independent walking.
Conclusion. Children needing ventilation have the worst short-term prognosis. However, irrespective of severity during acute
phase, good long-term recovery can be expected in most children. [Indian J Pediatr 2009; 76 (8) : 795-799] E-mail-
drnsankhyan@yahoo.co.in.
Key words: Prognosis; Outcome; GBS; Acute polyneuropathy
With the reduction of poliomyelitis, Guillain-Barré               all four limbs, cranial nerves and muscles of
syndrome (GBS) has become the most common cause of                respiration. During the acute phase disability can be
acute flaccid paralysis in both the developed and                 severe and can result in respiratory in-sufficiency and
developing countries. It affects 0.6-4 individuals per            death. 7 ,8 Age is an important factor determining
lakh population per year. 1 In the past, GBS was                  outcome, and prognosis in children is said to be
considered a single disease but now it has become clear           favorable as compared to adults. Several retrospective
that this clinical picture can be produced by different           pediatric studies have tried to look at factors affecting
pathological subtypes.2 In north America and Europe,              prognosis.9 ,10 However, studies prospectively looking
typical patients with GBS usually have the demyelinating          at the outcome in childhood GBS are sparse. Moreover
variant termed acute inflammatory demyelinating                   the regional variability in the predominant pathology of
polyneuropathy (AIDP).3 Studies from China, Japan, and            GBS may have important implications on prognosis as
Central and South America show that axonal forms of the           well. So, the present study was undertaken with a view
syndrome [acute motor axonal neuropathy(AMAN), acute              to prospectively evaluate the clinical profile, short term
motor sensory axonal neuropathy(AMSAN)] account for               and long term follow up of childhood GBS in Indian
30-47% of the cases.4 ,5 ,6 There is a paucity of comparable      population.
data from India.
     AIDP and the two axonal types usually cause                               MATERIAL AND METHODS
symmetric ascending flaccid paralysis, which can affect           This is a prospectively conducted study at a single
                                                                  tertiary care research center of North India. Over a
                                                                  period of three years (December 2003 to September
Correspondence and Reprint request: Dr. Naveen Sankhyan,          2006), all children with GBS aged <16 years were
Senior Resident, Division of Pediatric Neurology, Department of   enrolled for the study. Ethical clearance was obtained
Pediatrics, All India Institute of Medical Sciences, New Delhi,
                                                                  from the institutional ethics committee. Informed
110029, India
[DOI--10.1007/s12098--009--0125--y]                               consent was obtained from all parents before
[Received June 06, 2008; Accepted October 24, 2008]               enrollment. Many patients were actively sought as part
Indian Journal of Pediatrics, Volume 76—August, 2009                                                                    795
                                                  Veena Kalra et al
of a synchronous study investigating the relation                                   RESULTS
between previous Campylobacter jejuni infection and
Guillain-Barré syndrome. 11 Diagnosis of GBS was             Between Dec 2003 and Sep 2006, 52 children with a
accepted after children were examined at least once by       diagnosis of GBS were admitted to our center. The age
a consultant pediatric neurologist and the case fulfilled    range was 12 months to 15 years, median age being
the criteria of Asbury and Cornblath. 12 All patients        five years. There was a striking male preponderance,
diagnosed as GBS were admitted. IVIG therapy (2g/Kg          the female: male ratio being 1:3 (girls-13, boys-39).
over 2-5 days) was given in those unable to walk or had      Mortality during acute phase was 11.5%. Five of these
evidence of respiratory muscle weakness. 13 Till the         six children had respiratory failure; one each had
course was static or improving and there were no             respiratory failure with encephalopathy and bulbar
potentially life threatening features the child remained     paralysis with aspiration pneumonitis. A preceding
admitted.                                                    infective illness was reported in 30(57.7%) of children.
    Nerve conduction studies could be done in 33             Eleven had an upper respiratory infection, eight had
(63.4%) of the enrolled children. Motor nerve                diarrheal episode and eleven had a non-specific febrile
conduction, sensory nerve conduction and F wave              illness. Thirty one (59.6%) children had myalgias or
response studies were performed by using the standard        paraestheisas at the onset. Weakness was present in all
technique of supramaximal percutaneous stimulation           children at presentation. The median duration to peak
and surface electrode recording. Motor conduction was        weakness was seven days (range-1-24 days), and
studied in median, ulnar, tibial and common peroneal         majority (69.2%) had upper limb involvement in
nerves. Sensory conduction was studied in median,            addition to lower limb weakness. Bulbar weakness was
ulnar and sural nerves.                                      evident in 20(38.5%) and other cranial nerve
    Lumbar puncture was done at presentation or in the       involvement was seen in 10 (19.2%). Dysautonomia
second week of illness in those presenting early. All        was detected in 9(17.3%). Respiratory muscle weakness
children underwent stool poliovirus detection as per         was seen in 15(28.8%) out of which 10(19.2%) received
the national policy. For maintaining uniformity,             artificial ventilation. IVIG therapy was given to
outcome was assessed at one year after onset of illness      43(82.7%) children. Nerve conduction studies were
on the Likert scale. 14 In this scale; zero indicates-       done in 33 children, 18(54.5%) had reduced compound
Healthy: no signs or symptoms due to Guillain-Barré          muscle action potential amplitudes with normal
syndrome, 1- minor symptoms or signs and capable of          velocities indicative of axonal dysfunction or distal
running, 2-able to walk 5 m across an open space             demyelination, 5(15.1%) had reduced velocities
without assistance, walking frame, or stick but unable       indicating diffuse demyelination and 10(30.3%) had
to run, 3-able to walk 5 m across an open space with the     inexicitable nerves.
help of one person and waist level walking frame or             Long-term data was obtainable in 40 out of 46
sticks,4 chairbound or bedbound: unable to walk as in        children discharged after the acute phase of illness. The
3, 5-requiring assisted ventilation for at least part of     median follow up duration was 25 mth (Range:12-48
day or night, 6-dead.                                        mth). At one year follow up 87.5% of them (grade 0-28,
     For children with any disability at one year,           grade1-7) either recovered fully or had only minimal
outcome was assessed till last contact. Follow up was        symptoms. Among ambulatory children the median
assessed on outdoor follow up visits and also by             time to unaided ambulation was 42 days (5-360days).
telephonic interviews and by postal communication in         Among 15 children with respiratory muscle
all patients. At least three attempts (2 postal reminders)   involvement (10 - ventilated), 5 died in acute phase.
were made to contact all non responders. Out of a total      Among eight with follow up data, seven had good
of 52 children enrolled, 46 were alive at discharge and      recovery (grade <2) at one year and the lone child with
one year follow up was available in 40.                      functional grade 2 had recovered to grade 1 at 22 mth.
    The SPSS-15 statistical program was used for                Factors significantly associated with poor outcome
analysis. We compared the clinical, laboratory and           (grade 2-6) at one year follow up were; artificial
electrophysiological features among children with            ventilation, inexitable nerves on nerve conduction and
good outcome (score 0 or 1) and those with poor              delayed independent walking (Table 1). Of the 7 with
outcome (score 2-6). 15 Due to non-parametric                grade1 disability 2 were symptomless at 24 and 30
distribution of data, the Mann Whitney U test was used       months follow up, rest of the five had static disability
for continuous variables and Fischer’s exact test for        (Fig. 1). All 3 children with grade 2 disability had
categorical variables. We evaluated our findings             improved to grade 1 on follow up. One child with grade
against a two-tailed significance level of 5% (p<0.05).      3 disability had improved to grade 2 by 36 mth. One
The paucity of children with poor outcome prevented          child among those enrolled had a history of previous
us from identifying independent predictors using a           GBS and among those followed up, no case of recurrent
regression model.                                            GBS was seen.
796                                                             Indian Journal of Pediatrics, Volume 76—August, 2009
                                     Outcome in Childhood Guillain-Barré Syndrome
                        DISCUSSION
GBS was described more than a century back but the
data on prospective long term follow up of childhood
GBS is still sparse. Reports have suggested differences
in clinical presentation and course of this illness among
children as compared to adults. 7,8,9,14,15 Hence it is
imperative that data from pediatric cohorts is separately
evaluated. We bring results of the largest prospectively
collected data on outcome of GBS in Indian children.
    Males are reported to be around one and half times
more likely to develop GBS compared to females.2 But we
believe the striking male preponderance in our series is
in part related to the extra attention and concern shown
to the male child in this region of our country, accounting
for higher health facility visits for their illnesses. In a
prospective study of 95 children with GBS, 73.7% had a
recent infection.16 Fifty seven percent of the children in
the present study had a recent infection, upper                       Fig. 1. Flow of Children with GBS during the follow up period.
respiratory infections being the commonest.                                   *Duration of Follow up in months
    At the nadir of the illness, the disease is less severe in
                                                                      TABLE 2. Prognosis of GBS in Different Studies
children than adults, 30-40% are able to walk,8,15 13-20%
require artificial ventilation and 50% have                           Authors           Age range        Number Ventilated Mortality Recovery
dysautonomia. 7,15 Respiratory paralysis, secondary                                                             (%)        (%)       (%)
infections, bulbar weakness, multisystem involvement                  Paradiso et al5   14 mo-14 yr      61      13.1*     NA          82% (14-
and dysautonomia can be life threatening during the                                                                                    270 days)
acute phase. 8,15,17 Rates of mortality have varied in                Korinthenberg
                                                                      et al 7           11 mo-17.7 yr 155        16        NA          92.4%
different studies depending partly on the population                                                                                   (≥6 mo)
                                                                      Rantala et al 9     0.4-14.3 yrs   27      18.5      0           NA
                                                                      Briscoe et al 10    19 mo- 13 yr   23      4.3       4           NA
TABLE 1. Comparison of Children with Good and Poor                    Kleyweg et al    25
                                                                                          1-14 yrs       18      22        11.1        77% (Gr0/
         Outcome                                                                                                                       1 at 1 year)
                                                                      Rees et al 15     5-85 yrs         69      25        8.7         NA
Variable               Good recovery    Poor recovery       P value   Beghi et al8      3-87 yrs         297     14        11          70%
                                                                                                                           ( 1 year)   Present
                       (Gr <2) ‡         (Gr 2-6) ‡                   study             1-15 yrs         52      19.2      11.5        87.5 %(Gr
                       (n=35)           (n=11)                                                                                         0/1 at 1 yr)
Age (years)            5.6 ± 3.2        6.0 ± 4.2           0.92
                                                                      *Data on respiratory failure, NA- Not available
Male Gender            27 (77.1)        8(72.7)             1.0
Preceding infections† 22(62.9)          6(54.5)             0.72
Quadraparesis          23(64.5)         10(90.9)            0.14      studied, therapy and facilities (Table 2). In our series
Bulbar weakness        12(34.3)         6(54.5)             0.29      the high rate of ventilation (19.2%) and acute phase
Cranial neuropathy 7(20)                3(27.3)             0.68
                                                                      mortality(11.5%) reflect in part the severer end of the
Respiratory muscle
involvement            8 (22.9)         6(54.5)             0.06      disease spectrum seen at our center. Meticulous
Dysautonomia           7(20)            3(27.3)             0.68      respiratory care and monitoring and recognition of
Bladder involvement 1(2.9)              2(18.2)             0.14      bulbar weakness and dysautonomia could possibly
Onset to peak (days) 8.8 ± 5.8          10.7±6.2            0.33      reduce the mortality further.
CSF†† proteins (mg/dl) 77.4 ± 46.1      95.8±49.8           0.33         Immunotherapy has long been the mainstay of
Nerve conduction studies
  Reduced velocities 3(13)              1(14.3)             1.00      therapy of GBS apart from supportive care. Due to the
  Reduced                                                             ease    of    administration        and     lower    cost,
  amplitudes           15(65.2)         0(0)                0.006*    immunoglobulins are commonly used to treat GBS,
  In excitable nerves 5(21.7)           5(71.4)             0.026*    especially in those patients who are unable to walk. 13
IVIG therapy           28(80.0)         9(81.8)             0.89      We used IVIG; however its effect on outcome cannot be
Artificial ventilation 3(8.6)           5(45.5)             0.013*
Time to walk
                                                                      assessed in an uncontrolled trial like the present study.
independently (days) 61.0±53.9          168.7±139.3         0.026*       Artificial ventilation was associated with poor
                                                                      outcome in the present study. Need for ventilation
Number in parenthesis indicates percentage,                           indicates severity at the nadir, a variable found by most
†–preceding infections- include gastroenteritis, upper                researchers to have a bearing on outcome. 7,8,14,15,18 ,19
respiratory infections and non specific febrile illnesses
                                                                      Poorer outcome has also been related to low amplitude
††–data available for 42 of 46 patients analysed
‡Grades (0-6) as described in methods 14                              responses on nerve conduction,18 axonal degeneration 8
Indian Journal of Pediatrics, Volume 76—August, 2009                                                                                         797
                                                     Veena Kalra et al
or electrical non excitability.18,19 Previous reports and            features of Guillain-Barré syndrome. J Infect Dis 1997; 176:
our study, suggests that the finding of low amplitudes               S92–S98
                                                                 2   Hughes RAC, Cornblath DR. Guillain-Barré syndrome.
on nerve conductions may not necessary imply a bad
                                                                     Lancet 2005; 366: 1653–1666
outcome. 20 ,21 Two patterns of recovery are found in            3   Hadden RDM, Cornblath DR, Hughes RAC et al.
patients with AMAN; rapidly recovering conduction                    Electrophysiological classification of Guillain-Barré
block at the nodes of Ranvier and more protracted                    syndrome: clinical associations and outcome. Ann Neurol
recovery in those with extensive axonal degeneration.22              1998; 44: 780–788
In the present study too, two distinct patterns emerged,         4   McKhann GM, Cornblath DR, Griffin JW et al. Acute motor
                                                                     axonal neuropathy: a frequent cause of acute flaccid
a large majority with low CMAP’s and quick recovery
                                                                     paralysis in China. Ann Neurol 1993; 33: 333–342
and another group with inexicitable nerves and poor              5   Paradiso G, Tripoli J, Galicchio S, Fejerman N.
recovery. The finding of inexicitablity of nerves was an             Epidemiological, clinical, and electrodiagnostic findings in
indicator of poor outcome, in this and previous                      childhood Guillain-Barré syndrome: a reappraisal. Ann
reports.19,23 Inexicitablity can result either from axonal           Neurol 1999; 46: 701–707
degeneration or dysfunction or demyelination causing             6   Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki
complete conduction block.24 Other factors predicting                N. Axonal Guillain-Barré syndrome: relation to anti-
                                                                     ganglioside antibodies and Campylobacter jejuni infection in
poor outcome include, a protracted plateau time,                     Japan. Ann Neurol 2000; 48: 624-631.
change to chronic progressive or relapsing                       7   Korinthenberg R, Mönting JS. Natural history and treatment
neuropathy10,16 or concurrent myelitis.16 A longer time to           effects in Guillain-Barré syndrome: a multicentre study.
independent walking was an indicator of poorer long                  Arch Dis Child 1996;74: 281-287
term recovery in the present series.                             8   Beghi E,Bono A, Bogliun G et al .The prognosis and main
   Long term recovery in most pediatric series has been              prognostic indicators of Guillain-Barré syndrome , A
                                                                     multicentre prospective study of 297 patients ; The Italian
better compared to adults (Table 2). In the largest                  Guillain-Barré Study Group. Brain 1996;119:2053-2061
pediatric prospective study by Korinthenberg et al, at the       9   Rantala H, Uhari M, Niemelä. Occurrence, clinical
end of the observation period (288 days), 96% of children            manifestation, and prognosis of Guillain-Barré syndrome.
were either asymptomatic or had symptoms not affecting               Arch Dis Child 1991; 66: 706-709
daily functioning. 16 We also found the outcome to be           10   Briscoe DM, Mcmenamin JB, O’Donohoe NV. Prognosis of
excellent with full recovery or minimal symptoms in                  Guillain-Barré syndrome Arch Dis Child 1987;62:733-735
                                                                11   Kalra V, Chaudhry R, Dua T, Dhawan B, Sahu JK, Mridula
87.5% children at one year. Many of those with weakness
                                                                     B. “Association of campylobacter jejuni infection with
at one year continued to improve beyond one year too,                childhood Guillain-Barré syndrome: A case-control study”.
with 95% making good recovery at last follow up (Fig 1).             J Child Neurol 2008 (In Press)
This late recovery has been observed by other researches        12   Asbury AK, Cornblath DR. Assessment of current
too.23 The favorable long term outcome in children calls             diagnostic criteria for Guillain-Barré syndrome. Ann Neurol
for further large studies looking at early predictors of             1990; 27 (suppl): S21–S24.
                                                                13   Hughes RAC, Wijdicks EFM, Barohn R, et al. Practice
severity and mortality and effects of combinations,
                                                                     parameter: Immunotherapy for Guillain–Barré syndrome:
sequential administration and repeat courses of existing             Report of the Quality Standards Subcommittee of the
immunotherapies.                                                     American Academy of Neurology. Neurology 2003; 61;736-
                                                                     740
                      CONCLUSION                                14   Winer JB, Hughes RAC, Greenwood RJ, Perkin GD, Healy
                                                                     MJR. Prognosis in Guillain-Barré syndrome. Lancet
Excellent recovery can be expected in nearly all                     1985;i:1202-1203
children with GBS, provided respiratory, bulbar and             15   Rees JH, Thompson RD, Smeeton NC, Hughes RAC.
autonomic impairments during the acute phase are                     Epidemiological study of Guillain-Barré syndrome in south
managed meticulously. While most children recover                    east England. J Neurol Neurosurg Psychiatry 1998;64:74-77
                                                                16   Korinthenberg R, Schessl J, Kirschner J. Clinical presentation
within six months, continued improvement occurs
                                                                     and course of childhood Guillain-Barré syndrome: a
beyond one year.                                                     prospective multicentre study. Neuropediatrics 2007;38:10-
                                                                     17.
Contributions: The concept and design of the study was          17   Cole GF, Mathew DJ. Prognosis in severe Guillain-Barré
provided by VK, RC and BD. Data was collected, analyzed by           syndrome. Arch Dis Child 1987;62:288-291.
NS, S Gan. NS, SS reviewed the literature and drafted the       18   Winer JB, Hughes RAC, Osmond C. A prospective study
manuscript for which SG provided important inputs. The               of acute idiopathic polyneuropathy. I. Clinical features and
manuscript was finally revised and approved by VK,RC and BD.         their prognostic value. J Neurol Neurosurg Psychiatry
Conflict of Interest: None                                           1988;51:605-612.
Role of Funding Source: This study was supported by the         19   Ortiz C F. Factors affecting prognosis in childhood Guillain-
Department of Biotechnology, Govt. of India through financial        Barré syndrome. Rev Neurol 2004 ;38:518-523.
grant reference D.O.No.BT/PR2193/Med/09/322/2000.               20   Bradshaw DY, Jones HR. Guillain-Barré syndrome in
                                                                     children: Clinical course, electrodiagnosis, and prognosis.
                      REFERENCES                                     Muscle Nerve 1992;15: 500-506.
                                                                21   Hiraga A, Mori M, Ogawara K et al. Recovery patterns and
  1 Hughes RAC, Rees JH. Clinical and epidemiological
                                                                     long term prognosis for axonal Guillain-Barré syndrome.
798                                                               Indian Journal of Pediatrics, Volume 76—August, 2009
                                   Outcome in Childhood Guillain-Barré Syndrome
     J Neurol Neurosurg Psychiatry 2005; 76: 719–722.             2 4 Berciano J, Figols J, García A et al. Fulminant Guillain-Barré
 2 2 Kuwabara S, Asahina M, Mori M et al. Two patterns of             syndrome with universal inexcitability of peripheral nerves:
     clinical recovery in Guillain-Barré syndrome with anti-GM1       A clinicopathological study. Muscle Nerve 1997; 20: 846-857
     antibody. Neurology 1998;51:1656-660.                        2 5 Kleyweg RP, Van der Meché FGA, Loonen MCB, De Jonge J,
 2 3 Fletcher DD, Lawn ND, Wolter TD, Eelco FM. Long term             Knip B. The natural history of the Guillain-Barré syndrome
     outcome in patients with Guillain-Barré syndrome requiring       in 18 children and 50 adults. J Neurol Neurosurg Psychiatry
     mechanical ventilation. Neurology 2000;54: 2311-2315.            1989; 52: 853-856.
Indian Journal of Pediatrics, Volume 76—August, 2009                                                                           799